Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 09 Apr 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Mirae Asset Large Cap Fund |
|---|---|
| 09 Apr 2008 | ₹100.00 |
| 20 Oct 2009 | ₹123.06 |
| 02 May 2011 | ₹138.80 |
| 11 Nov 2012 | ₹132.52 |
| 24 May 2014 | ₹151.85 |
| 04 Dec 2015 | ₹176.56 |
| 15 Jun 2017 | ₹199.87 |
| 25 Dec 2018 | ₹168.73 |
| 06 Jul 2020 | ₹158.35 |
| 16 Jan 2022 | ₹249.36 |
| 29 Jul 2023 | ₹262.23 |
| 07 Feb 2025 | ₹293.01 |
| 20 Aug 2026 | ₹291.26 |
| Metric | Mirae Asset · Regular · IDCW NAV ₹29.07 Very High risk ★★★☆☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| -7.93% | -5.49% | |
| +3.84% | +7.73% | |
| +5.41% | +6.21% | |
| +5.42% | +4.02% | |
| +5.99% | +5.54% | |
| +3.33% | — | |
| +6.99% | +6.92% | |
| +6.62% | +6.12% | |
| +5.80% | +3.99% | |
| Risk | ||
| 14.39% | 14.74% | |
| -0.18 | 0.02 | |
| -0.24 | 0.03 | |
| -51.29% | -48.01% | |
| Nifty 100 | — | |
| -5.41% | -1.74% | |
| 0.95 | 0.98 | |
| 83.4% | 93.8% | |
| 113.3% | 102.3% | |
| 1.70% | 2.38% | |
| ₹38,017Cr | ₹1,495Cr | |
| 1.00% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| 20% | 58% | |
| Gaurav Misra · 7.6y | — | |
| 09 Apr 2008 | — | |
| 80 | — | |
| 47.7% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.